Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Notes Payables (2016 - 2018)

Marker Therapeutics (MRKR) has disclosed Notes Payables for 4 consecutive years, with $5000.0 as the latest value for Q3 2018.

  • Quarterly Notes Payables changed 0.0% to $5000.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Sep 2018, changed 0.0% year-over-year, with the annual reading at $5000.0 for FY2017, 0.0% changed from the prior year.
  • Notes Payables for Q3 2018 was $5000.0 at Marker Therapeutics, roughly flat from $5000.0 in the prior quarter.
  • The five-year high for Notes Payables was $52942.0 in Q1 2015, with the low at $5000.0 in Q1 2016.
  • Average Notes Payables over 4 years is $17455.1, with a median of $5000.0 recorded in 2016.
  • The sharpest move saw Notes Payables plummeted 90.56% in 2016, then changed 0.0% in 2017.
  • Over 4 years, Notes Payables stood at $30000.0 in 2015, then crashed by 83.33% to $5000.0 in 2016, then changed by 0.0% to $5000.0 in 2017, then changed by 0.0% to $5000.0 in 2018.
  • According to Business Quant data, Notes Payables over the past three periods came in at $5000.0, $5000.0, and $5000.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.